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1 Introduction and goals 
 
Genetic and biochemical studies in the yeast Saccharomyces cerevisiae have been 
instrumental in yielding an understanding of the pathways and mechanisms that 
eukaryotic cells employ to rescue the replication fork stalled at DNA lesion sites. Unless 
rescued in a timely and orderly fashion, the stalling of replication can lead to DNA strand 
breaks and result in chromosome rearrangements and enhanced rates of carcinogenesis. 
The Rad6–Rad18 ubiquitin-conjugating complex of yeast governs at least three 
alternative pathways that promote replication through DNA lesions: DNA polymerase 
Polη, Pol ζ and Rev1 dependent translesion synthesis (TLS), and an Mms2–Ubc13–Rad5 
dependent error-free postreplicational repair (PRR) pathway. Polη, for example, 
promotes efficient and relatively error-free synthesis through UV-induced cyclobutane 
pyrimidine dimers; consequently, inactivation of Polη in both yeast and humans confers 
enhanced UV mutagenesis and in humans causes the variant form of Xeroderma 
Pigmentosum (XP-V), a cancer-prone syndrome. The Mms2–Ubc13–Rad5-dependent 
pathway promotes the repair of discontinuities that form in the newly synthesized strand 
opposite from DNA lesions. Although the mechanism by which the Rad5 pathway 
operates is not well known, it likely utilizes a template switching mechanism, wherein the 
newly synthesized daughter strand of the undamaged complementary sequence is used as 
the template for bypassing the lesion. Rad5, a member of the SWI/SNF family of 
ATPases, exhibits a DNA-dependent ATPase activity, and it also has a C3HC4 RING 
motif, characteristic of ubiqutin ligases. Ubiquitin ligases promote the protein 
ubiquitylation reaction by binding the cognate ubiqutin-conjugating (UBC) enzyme as 
well as the protein substrate and by positioning them optimally for efficient ubiqutin 
conjugation to occur. Rad5 physically associates with the Mms2– Ubc13 complex via 
Ubc13, and it also interacts with the Rad18 subunit of the Rad6–Rad18 complex. Both 
the ATPase and ubiqutin ligase activities of Rad5 are essential for PRR, as the repair of 
discontinuities formed in the newly synthesized DNA in UV irradiated cells becomes as 
highly impaired in the rad5 mutants defective in either of these functions as in the rad5 
mutant. In DNA damaged yeast cells, proliferating cell nuclear antigen (PCNA) becomes 
monoubiquitylated by Rad6–Rad18; subsequently, this lysine residue is polyubiquitylated 
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via in an Mms2–Ubc13–Rad5- dependent manner. Although the biochemical evidence is 
lacking, genetic evidence in yeast is consistent with a role of Rad5 acting as a ubiqutin 
ligase in Mms2–Ubc13-dependent polyubiquitylation of PCNA. All three Rad6–Rad18 
dependent lesion bypass pathways are rendered inactive in the absence of PCNA 
ubiquitylation. Monoubiquitylation of PCNA is necessary for TLS by Polη, Pol ζ and 
Rev1, and polyubiquitylated PCNA activates the Rad5-dependent PRR pathway. PCNA 
polyubiquitylation is a necessary prerequisite for the activation of this PRR pathway. 
The various elements of the Rad6–Rad18 pathway have been conserved in higher 
eukaryotes, including in humans. Also, similar to that in yeast, PCNA is 
monoubiquitylated and then polyubiquitylated in response to treatment with DNA 
damaging agents. Although for humans the various TLS polymerases that promote lesion 
bypass in a Rad6–Rad18-dependent manner have been described and the Mms2–Ubc13 
complex has been identified, the evidence for a Rad5 counterpart has been lacking thus 
far. 
           Our goals were to elucidate whether a homologue yeast Rad5-like damage-bypass 
system operates in human cells, and to understand how human cells replicate damaged 
DNA with the following experimental approaches: 
            1. Database screen to identify the structural homologues of  the yeast Rad5 
2. Complementation studies 
We tested whether the identified structural homologues, HLTF and SHPRH, 
could complement the UV and RTG   sensitivity of yeast  strains devoid of Rad5 
function. 
2. Interaction studies 
We examined whether HLTF and SHPRH  could associate in vivo and in vitro  
with Rad6–Rad18, Mms2–Ubc13, and PCNA. 
 3. Stimulation of the poliubiquitination of PCNA 
We examined whether HLTF and SHPRH could stimulate the poliubiquitilation 
of PCNA in vivo and in vitro. 
 4. DNA fiber studies  
 We investigated if HLTF has a role in the replication of damaged DNA 
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2 Methods 
 
Recombinant DNS technics 
 -Polymerase chain reaction (PCR) and  PCR based mutagenesis 
 -Restrictin enzyme digestions of DNA 
 -Ligation of DNA fragments 
 -Agarose gel electrophoresis 
 
Proteins 
 -Expression and purification of proteins from yeast  
 -GST pull down 
 -In vitro ubiquitilation  
 
Cell culture 
 -coimmunoprecipitation 
 -In vivo ubiqutilation 
 -Analysis of the DNA replication with DNA fiber method 
 
Yeast genetics 
 -Complementation experiments 
 
Computer based methods 
 -Multiple alignement os protein sequences 
 -Protein database filtering 
 
 
 
 
 
 
 
 
 4
3 Results and discussion 
3.1 Identification of the human homologues of the yeast Rad5 
Human HLTF shows 43% similarity to Saccharomyces cerevisiae Rad5 protein at 
the amino acid level, while human SHPRH and yeast Rad5 proteins reveals 37% 
similarity. Both proteins contain the seven motifs found in helicases and the SNF2 family 
of ATP-hydrolyzing proteins, a RING domain characteristic of ubiquitin ligases, and they 
share the unusual domain structure in which the RING domain is inserted between 
helicase domains III and IV. SHPRH has two additional protein domains: a histone H1 
and H5 linker sequence and a PHD domain that are not present in Rad5. HLTF and Rad5 
have the HIRAN domain in the N terminus that has been proposed to function as a DNA-
binding domain for recognizing damaged DNA or a stalled replication fork, followed by 
a leucine heptad repeat motif. Thus, throughout the entire sequence, HLTF shows a much 
higher degree of homology to yeast Rad5 than does SHPRH. 
3.2 HLTF is able to partially complement the UV sensitivity of a yeast Rad5 
deletion mutant 
Prompted by the high degree of sequence conservation, we tested whether HLTF and 
SHPRH could complement the UV sensitivity of yeast strains devoid of Rad5 function. 
Because we were not able to observe a considerable increase in UV resistance when we 
expressed HLTF or SHPEH in a rad5Δ yeast strain, to increase the sensitivity of the 
assay further, we examined the complementation of the UV sensitivity of the 
rad5Δrad30Δ strain by HLTF and SHPRH. Because of the simultaneous inactivation of 
two lesion bypass pathways, the rad5Δrad30Δ strain exhibits a much higher level of UV 
sensitivity than the rad5Δ strain. Interestingly, we found that HLTF greatly increases the 
UV resistance of rad5Δrad30Δ mutant cells but SHPRH did not show any 
complementing effect. 
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3.3 Complex formation of HLTF and SHPRH with Rad6–Rad18 and Mms2–
Ubc13 and PCNA 
To establish that HLTF and SHPRH function in human cells in a Rad5-like manner, we 
next examined whether they could associate in vivo and in vitro with Rad6–Rad18, 
Mms2–Ubc13, and PCNA.  
In the in vivo experiments we examined these interactions in human embryonic 
kidney 293FT cells. To facilitate the detection of the interactions, plasmids expressing 
HA-tagged Rad18, Mms2, Ubc13, or PCNA were cotransfected into cells together with 
FLAG-tagged HLTF or FLAG-tagged SHPRH. Next, we immunoprecipitated FLAG-
HLTF or FLAG-SHPRH and the associated proteins from cell lysates by using anti-
FLAG beads, and the precipitated proteins were analyzed for the presence of HA-tagged 
proteins with anti-HA antibody. We observed a coprecipitation of HLTF with Rad18, 
Mms2, Ubc13 and PCNA, while only Ub13 coprecipitated with SHPRH. 
To provide further evidence for the complex formation of HLTF and SHPRH with 
Rad6–Rad18 and Mms2–Ubc13, we purified these proteins and tested them for direct 
physical interaction with GST pull down. We observed that in this in vitro experimental 
condition both HLTF and SHPRH are able to associate with the Rad6-Rad18 and with the 
Mms2-Ubc13 complex. 
3.4 HLTF and SHPRH stimulate the poliubiquitilation of PCNA 
In yeast, upon DNA damage Rad6–Rad18 monoubiquitinates PCNA, and the 
monoubiquitinated form of PCNA is further polyubiquitinated by the combined action of 
Rad5 and Mms2–Ubc13. Similar to Rad5, complex formation of HLTF and SHPRH with 
the Rad6–Rad18 and Mms2–Ubc13 enzymes indicated that they might act together as a 
multisubunit ubiquitin-conjugating complex for PCNA ubiquitination. To explore this 
possibility, first we examined whether HLTF and SHPRH could promote the 
polyubiquitination of PCNA. 
We examined overexpressed HA–PCNA for ubiquitination in the presence of 
overexpressed 5His-ubiquitin in HEK293FT cells. In this experimental system, we first 
enriched His-ubiquitinated proteins on nickel beads followed by detection of 
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ubiquitinated HA–PCNA by HA antibody and observed that overexpression of HLTF 
markedly stimulated PCNA polyubiquitination 
Next, we investigated whether HLTF and SHPRH can catalyze the 
polyubiquitination of PCNA in vitro by using highly purified proteins. We have already 
shown that for PCNA monoubiquitination to occur by Rad6–Rad18, PCNA first has to be 
loaded onto DNA by replication factor C (RFC). Therefore, first we preincubated PCNA 
with RFC and DNA followed by the addition of ubiquitin, Uba1, and various 
combinations of HLTF or SHPRH, Rad6–Rad18, and Mms2–Ubc13. As expected, Rad6–
Rad18 monoubiquitinated PCNA and the addition of Mms2-Ubc13 to this reaction did 
not have any effect on PCNA ubiquitination. Importantly, however, the addition of HLTF 
or SHPRH to the Rad6–Rad18 and Mms2–Ubc13-containing reaction resulted in the 
polyubiquitination of PCNA, where almost all of the monoubiquitinated form of PCNA 
was converted to polyubiquitinated species 
3.5 HLTF has a role in the replication of damaged DNA 
Our findings promted us to investigate whether HLTF promotes the replication of 
damaged  DNA in vivo. We examined the effect of knocking down the expression of 
HLTF by siRNA on the progress of individual replication-forks, on damaged DNA using 
the chromosomal fiber technique.  
We found that the recovery of the progression of the replication fork after DNA 
damage was impaired in cells in which HLTF level was reduced compared to control 
cells. Considering those individual replication forks which were active even on the 
damaged DNA we also compared the rate of replication before and after MMS treatment. 
These studies revealed that after DNA damaging treatment, the progression of replication 
forks is slowed down to a much greater extent in HLTF knocked down cells than in 
control cells. These results indicate that HLTF affects the resumption of DNA synthesis 
at replication forks stalled at DNA lesion sites.  
 
We have provided biochemical in vivo evidences, that two putative human tumor 
suppressor proteins, HLTF and SHPRH are functional homologues of yeast Rad5 and 
that they act as a ubiquitin ligase for promoting Mms2–Ubc13-dependent 
polyubiquitylation of PCNA.  
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In yeast, the Rad5–Mms2–Ubc13-dependent PRR pathway promotes lesion 
bypass in an error-free manner. For UV lesion, in addition to this pathway, Polη also 
contributes to error-free bypass via its role in promoting error-free TLS through 
cyclobutane pyrimidine dimers. Consequently, the frequency of UV induced mutations 
rises dramatically when both the Rad5-dependent PRR and Polη-dependent TLS 
pathways are inactivated. The inactivation of Polη in humans also leads to an increase in 
the frequency of UV induced mutations and causes the cancer-prone syndrome, the 
variant form of xeroderma pigmentosum. Also, there is evidence in human cells that 
inactivation of Mms2 leads to an enhancement of mutation frequencies, and that PCNA 
polyubiquitylation protects human cells against mutations caused by TLS. Overall, the 
evidence for both yeast and human cells is consistent with a role for the Rad5–Mms2–
Ubc13 complex in promoting error-free lesion bypass. 
We expect HLTF and SHPRH to resemble Rad5 in promoting error-free lesion 
bypass. Such a role predicts that inactivation of HLTF or SHPRH would confer elevated 
levels of mutagenesis, resulting from the increased dependence on the TLS polymerases 
for lesion bypass. In this regard, it is of interest to note that loss of heterozygosity at the 
human chromosomal band region 6q24-q27, where the SHPRH gene is located, has been 
observed in multiple human malignancies, particularly in melanomas and breast and 
ovarian cancers. Moreover, sequence analysis of 44 melanoma and ovarian tumor cell 
lines has identified four mutations in the SHPRH gene, whereas none of these mutations 
are seen in normal cell lines; three of these mutations were observed in the hemizygous 
or homozygous state, indicating a complete lack of functional SHPRH protein in these 
cell lines. A cancer suppressor role for HLTF is indicated from the observations that loss 
of HLTF expression accompanied by HLTF promoter methylation occurs in as many as 
50% of colon and gastric cancers. 
These observations, taken together with our evidence that HLTF and SHPRH are 
a ubiquitin ligase for mediating Mms2–Ubc13-dependent PCNA polyubiquitylation, and 
the fact that this pathway promotes error-free replication through the DNA lesions, raise 
the strong possibility that HLTF and SHPRH function provides an important deterrent to 
mutagenesis and carcinogenesis in human cells. 
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